Insulin glargine and lixisenatide Subcutaneous and Xolegel CorePak
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Xolegel CorePak and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: hydrocortisone / ketoconazole topical
Brand name: Xolegel CorePak
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Xolox
- Insulin glargine and lixisenatide Subcutaneous-Xopenex
- Insulin glargine and lixisenatide Subcutaneous-Xopenex Concentrate
- Insulin glargine and lixisenatide Subcutaneous-Xopenex HFA
- Insulin glargine and lixisenatide Subcutaneous-Xopenex Inhalation Solution Concentrate
- Insulin glargine and lixisenatide Subcutaneous-Xopenex Pediatric
- Xolegel CorePak-Insulin glargine, recombinant Subcutaneous
- Xolegel CorePak-Insulin glulisine
- Xolegel CorePak-Insulin Glulisine (Cartridges and Pens)
- Xolegel CorePak-Insulin Glulisine (Vials)
- Xolegel CorePak-Insulin glulisine Subcutaneous
- Xolegel CorePak-Insulin human inhaled Inhalation